David Shapiro Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Shapiro.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Shapiro. David Shapiro is CMO and EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of David Shapiro
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 18,703 | |
| Sep 17 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 286.75 | 1,000 | 286,750 | 14,253 | 15.3 K to 14.3 K (-6.56 %) |
| Sep 17 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 279.33 | 3,000 | 838,001 | 15,253 | 18.3 K to 15.3 K (-16.44 %) |
| Sep 17 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 18,253 | 14.3 K to 18.3 K (+28.06 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 26,703 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 9,735 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 247.65 | 849 | 210,257 | 15,027 | 15.9 K to 15 K (-5.35 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 246.00 | 1,000 | 246,000 | 15,876 | 16.9 K to 15.9 K (-5.93 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 244.75 | 2,000 | 489,499 | 16,876 | 18.9 K to 16.9 K (-10.60 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.53 | 1,187 | 286,696 | 18,876 | 20.1 K to 18.9 K (-5.92 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 20,063 | 16.1 K to 20.1 K (+24.90 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 16,063 | 14.4 K to 16.1 K (+11.24 %) |
| Jun 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 30,703 | |
| Jun 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 279.62 | 2,160 | 603,976 | 14,440 | 16.6 K to 14.4 K (-13.01 %) |
| Jun 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 278.55 | 840 | 233,982 | 16,600 | 17.4 K to 16.6 K (-4.82 %) |
| Jun 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 274.63 | 1,000 | 274,630 | 17,440 | 18.4 K to 17.4 K (-5.42 %) |
| Jun 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 18,440 | 14.4 K to 18.4 K (+27.70 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,327 | 45,001 | 4,326 | |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 368.90 | 500 | 184,451 | 7,218 | 7.7 K to 7.2 K (-6.48 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 368.02 | 2,400 | 883,246 | 7,718 | 10.1 K to 7.7 K (-23.72 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 366.91 | 1,240 | 454,972 | 10,118 | 11.4 K to 10.1 K (-10.92 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 365.37 | 1,632 | 596,279 | 11,358 | 13 K to 11.4 K (-12.56 %) |
| Feb 18 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,327 | 45,001 | 12,990 | 8.7 K to 13 K (+49.95 %) |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,800 | 32,933 | 50,719 | |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 5,168 | 53,748 | 47,620 | |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 73.09 | 928 | 67,826 | 8,663 | 9.6 K to 8.7 K (-9.68 %) |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 71.56 | 4,000 | 286,239 | 9,591 | 13.6 K to 9.6 K (-29.43 %) |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,800 | 32,933 | 13,591 | 9.8 K to 13.6 K (+38.81 %) |
| Jan 10 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 5,168 | 53,748 | 9,791 | 4.6 K to 9.8 K (+111.79 %) |
Page: 1